CD276 and cancer: We next asked whether mTORC1 and CD276 are associated with immune cell signatures in cancer by analyzing the pan-TCGA data using the 6 core immune subtypes (C1-C6) identified by Thorsson et al. 40 mTORC1 scores appear to be similar in all 6 immune subtypes (Fig. 1k).